Hyperbaric oxygen for hearing loss and tinnitus
- Conditions
- Acute, sudden sensorineural hearing loss, with or without tinnitus where no definite cause can be identified.Ear - Deafness
- Registration Number
- ACTRN12609000619246
- Lead Sponsor
- Michael Bennett
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 225
All adult patients (>18 yrs) presenting with idiopathic sudden sensorineural hearing loss (ISSHL), with or without tinnitus and where the first hyperbaric session can be administered within 14 days of the onset of symptoms. Diagnosis will exclude other causes of sudden hearing loss historically (e.g. Menieur’s disease, barotrauma, noise-induced hearing loss, ototoxic drugs) and by a magnetic resonance image (MRI) of the affected side to exclude an acoustic neuroma or other tumour.
Patient refusal (HBOT will not be offered to those who refuse to participate),
Contraindications to HBOT including inability to equalise the middle ear or respiratory sinuses, claustrophobia, pneumothorax, previous bleomycin administration or severe respiratory disease with carbon dioxide retention, presence of hearing decrement (documented) for greater than two weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method